EVFM - Evofem Biosciences, Inc.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 0.009

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.01 - $ 0.02

Volume

255,375

Average Volume

Market Cap

1.08M

Beta (5Y Monthly)

$ 0.74

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-15-2025	03-31-2025	10-Q
4	03-24-2025	12-31-2024	10-K
5	11-14-2024	09-30-2024	10-Q
6	08-14-2024	06-30-2024	10-Q
7	05-15-2024	03-31-2024	10-Q
8	03-27-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-14-2023	06-30-2023	10-Q
11	06-16-2023	03-31-2023	10-Q
12	04-27-2023	12-31-2022	10-K
13	01-06-2023	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-10-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	03-04-2021	12-31-2020	10-K
21	11-09-2020	09-30-2020	10-Q
22	08-04-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	03-12-2020	12-31-2019	10-K
25	11-07-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	03-01-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-02-2018	06-30-2018	10-Q
31	05-14-2018	03-31-2018	10-Q
32	02-26-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-10-2017	06-30-2017	10-Q
35	05-11-2017	03-31-2017	10-Q
36	03-23-2017	12-31-2016	10-K
37	11-10-2016	09-30-2016	10-Q
38	08-11-2016	06-30-2016	10-Q
39	05-12-2016	03-31-2016	10-Q
40	03-29-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evofem Biosciences Q3 EPS $(0.01) Up From ...
11/13/2025 23:14:09

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0....

Evofem Biosciences Sets September 26 Speci...
09/09/2025 13:29:50

-- Special Meeting to be held on September 26, 2025 --SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders tod...

Evofem Biosciences Q2 EPS $(0.02), Sales $...
08/14/2025 12:49:21

Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.02) per share. The company reported $4.825 million in sales thi...

Windtree Signs Deal With A Pharmaceutical ...
06/26/2025 20:13:41

Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreementContract inked with outside U.S m...

Evofem Biosciences Q1 Sales $845.00K Down ...
05/15/2025 13:56:58

Evofem Biosciences (OTC:EVFM) reported $845.00 thousand in sales this quarter. This is a 76.55 percent decrease over sales of $...

'FDA Commissioner Says 'no Plans' To Pull ...
04/24/2025 15:54:48

https://www.semafor.com/article/04/24/2025/fdas-marty-makary-no-plans-to-pull-abortion-pill-mifepristone

Evofem Partners With Windtree Therapeutics...
03/26/2025 12:49:13

Evofem's Cost to Manufacture PHEXXI will Decrease by 55% - 60% --SAN DIEGO, March 26, 2025 /PRNewswire/ -- Evofem Bioscienc...

Windtree Enters License And Supply Agreeme...
03/20/2025 12:06:20

Aditxt Purchased $2.28M Of Evofem Series F...
10/28/2024 12:17:45

Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating ...

Evofem Biosciences Files Preliminary Proxy...
09/24/2024 12:34:18

Companies Targeting Closing in Fourth Quarter of 2024Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), an...

Aditxt and Evofem Biosciences shares are t...
09/09/2024 15:01:27

Evofem Biosciences Addresses Impact Of GLP...
08/20/2024 12:19:36

As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Bioscie...

Aditxt And Evofem Amend Merger Agreement, ...
07/17/2024 10:36:25

This amended and restated Merger Agreement, among others, addresses pre-closing issues critical for Evofem's future success...

Aditxt Said On April 26 Received Notice Fr...
05/03/2024 10:05:21

-8-K

'France becomes first country to explicitl...
03/04/2024 17:53:02

https://www.washingtonpost.com/world/2024/03/04/france-abortion-constitution/

Laidlaw & Co. Downgrades Evofem Bioscience...
12/13/2023 09:25:56

Laidlaw & Co. analyst Yale Jen downgrades Evofem Biosciences (OTC:EVFM) from Buy to Hold.

why-is-life-sciences-focused-aditxt-stock-trading-higher-today

Why Is Life Sciences-Focused Aditxt Stock ...
12/12/2023 15:18:59

Aditxt Inc (NASDAQ: ADTX) has agreed to acquire Evofem Biosciences Inc (OTC: EVFM) in consideration of the issuance of a combin...

Aditxt, Inc. Enters Into Definitive Agreem...
12/12/2023 13:34:29

Evofem posted $13.4 million in net sales of Phexxifor the first nine months of 2023;Aditxt looks to accelerate Evofem into the ...

Evofem Biosciences Announces Padagis Will ...
09/27/2023 12:49:05

-- Padagis Determined They Will Not Challenge the Phexxi Patents -- -- Evofem Has Phexxi Patent Protection Through 2033 --

Evofem Biosciences Plans 1-For-125 Reverse...
05/17/2023 20:52:20

On Thursday May 18, 2023, the Company's common stock will open for trading under a new CUSIP (30048L302) on the OTC Venture...